Business Context and Reporting Period
Company: Spherix Incorporated (formerly Biospherics Incorporated; Note: Input metadata listed "Dominari Holdings Inc." but the filing text identifies the registrant as Spherix Incorporated).
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2003
Business Overview: The Company operates two primary segments: InfoSpherix, which provides government and commercial information services (contact centers, reservation systems), and BioSpherix, a biotechnology division focused on the development of tagatose (a low-calorie sweetener) and other proprietary products. InfoSpherix generated 94% of total revenue in 2003.
Key Financial Metrics
| Metric | 2003 | 2002 |
|---|---|---|
| Total Revenue | $18,086,711 | $15,131,855 |
| Net Loss | $(2,256,770) | $(2,921,926) |
| Net Loss Per Share (Diluted) | $(0.20) | $(0.26) |
| Total Assets | $14,167,257 | $15,453,140 |
| Working Capital | $5,043,672 | $8,787,502 |
| Cash and Cash Equivalents | $4,267,001 | $8,656,069 |
| Long-Term Debt | $63,310 | $90,530 |
| Bank Line of Credit (Outstanding) | $1,716,743 | $722,384 |
Cash Flow Summary (2003): Net cash outflow of $4.4 million, consisting of $686,000 used in operating activities, $2.3 million in investing activities, and $1.4 million in financing activities.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 19.5% to $18.1 million, driven by a 13% increase in InfoSpherix revenue and a significant one-time recognition of $1 million in BioSpherix revenue from an arbitration settlement.
- Net Loss Reduction: Net loss improved by approximately $665,000 compared to 2002. This was primarily due to the $1 million settlement revenue and improved InfoSpherix performance, partially offset by a 29% increase in Selling, General, and Administrative (SG&A) expenses.
- Legal Expenses: SG&A expenses rose by $1.3 million, largely due to $1.6 million in legal costs (up from $553,000 in 2002) related to the Arla arbitration and National Park Service (NPS) contract disputes.
- Liquidity: Working capital decreased by $3.7 million to $5.0 million. Cash reserves dropped by $4.4 million due to capital expenditures ($2.2 million) and legal settlements.
- Segment Performance:
- InfoSpherix: Revenue increased to $17.1 million. Operating loss narrowed to $787,000.
- BioSpherix: Revenue increased to $1.03 million (including the $1M settlement). Operating loss narrowed to $1.49 million.
Guidance, Outlook, Risks, and Unusual Items
Management Commentary and Outlook
- InfoSpherix: Future performance depends on the rebid of major contracts (NPS and Maryland Information Center) and expansion of the ReserveWorld business. The NPS contract was extended through September 30, 2004, pending a competitive rebid in Spring 2004.
- BioSpherix: Future results depend on the licensee (Arla Foods) commercializing tagatose for food/beverage and Spherix's marketing of "Naturlose" for non-food/drug uses. The company expects residual legal costs to be insignificant in 2004.
- Capital Resources: The Company has a $2 million line of credit with $283,000 available as of year-end. Management believes funds are adequate to meet obligations for the balance of 2004 even if the line is not renewed.
Risks and Contingencies
- Customer Concentration: Revenue is heavily dependent on a few large government contracts. In 2003, the U.S. Government, State of Michigan, and State of Maryland each accounted for over 10% of total revenue.
- Contract Uncertainty: The NPS reservation system contract faces a competitive rebid in 2004. The Company has protested the government's intention to award camping inventory for 12 national parks non-competitively to a competitor.
- Product Commercialization: BioSpherix's success relies on Arla's sales of tagatose. While sales began in 2003, future royalties are uncertain. The FlyCracker pesticide product was discontinued in January 2004 due to insufficient sales.
- Valuation Allowance: The Company maintains a full valuation allowance against net deferred tax assets due to accumulated losses.
Unusual Items
- Arla Settlement: A $1 million payment previously classified as deferred revenue was recognized as revenue in 2003 following a settlement of arbitration regarding tagatose commercialization delays.
- Inventory Write-down: A $100,000 loss was recorded on FlyCracker inventory, with the company expecting to recover only half of the original cost.
Investor Verification Checklist
- Contract Renewals: Verify the outcome of the Spring 2004 competitive procurement for the combined NPS and National Recreation and Reservation System (NRRS) contracts.
- Legal Resolution: Confirm that the $1.6 million in legal expenses incurred in 2003 are fully resolved and that no significant residual costs remain for 2004.
- Tagatose Royalties: Monitor Arla Foods' sales volume of tagatose to determine if future royalty revenue will materialize beyond the one-time settlement.
- Liquidity Position: Assess the renewal status of the $2 million Bank of America line of credit, which expires June 30, 2004, and the company's ability to fund operations without it.
- Customer Concentration: Review the specific terms and renewal probabilities of the top three government contracts (U.S. Gov, Michigan, Maryland) which drive the majority of revenue.